Form 4: Silicon Laboratories Executive Sells Shares Under 10b5-1 Trading Plan
SEC Form 4 Filing
Robert J. Conrad, Sr VP Worldwide Operations at Silicon Laboratories, sold 1,172 shares of common stock at $130 per share on May 13, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Robert J. Conrad, a Senior VP at Silicon Laboratories, sold 1,172 shares of the company's common stock on May 13, 2025.
- The sale was executed at a price of $130 per share.
- The transaction was conducted under a pre-existing 10b5-1 trading plan.
- Following the transaction, Conrad directly owns 15,972 shares of Silicon Laboratories.
- The filing indicates that Conrad is an officer of the company.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to an executive's stock sale under a pre-arranged plan. It doesn't inherently indicate positive or negative sentiment.
Industry Context
Sales by company executives are a normal part of corporate governance. The use of a 10b5-1 trading plan suggests the executive planned the sale in advance to avoid accusations of insider trading.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder confidence, but the use of a 10b5-1 plan mitigates concerns about insider trading.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of stock sale transaction. |
| 05/14/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Silicon Laboratories, SLAB, Robert J. Conrad, 10b5-1 Trading Plan, Stock Sale, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.